CTIS2023-504143-14-00进行中（未招募）1 期
Metamizole as pain treatment in patients with chronic pancreatitis, a multicenter, randomized, double-blind, placebo-controlled trial.
Stichting Radboud University Medical Center0 个研究点目标入组 76 人开始时间: 2023年7月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 76
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Confirmed chronic pancreatitis, Abdominal pain typical for chronic pancreatitis (i.e. dull epigastric pain), NRS = 3, = 3 days/week for two weeks
排除标准
- •Endoscopic or surgical intervention < 3 months prior to inclusion, Expected endoscopic or surgical intervention for CP within trial duration (6 weeks), Usage of more than 90 morphine milligram equivalents per day, Active use of metamizole at inclusion, Contra-indications to metamizole, Pancreatic carcinoma, •Start of amitriptyline, pregabalin or gabapentin less than 6 weeks prior to inclusion
研究者
相似试验
已完成
不适用
Reducing pain and disability in patients with chronic musculoskeletal pain with a stretch class - A randomised controlled trialSigns and Symptoms: PainSigns and SymptomsPainISRCTN22547605Department of Health171
已完成
不适用
se of Metamizole in a Brazilian populatioRBR-5mfy5txSanofi-Aventis Farmacêutica Ltda.
进行中（未招募）
不适用
The Evaluation of Bardoxolone Methyl in Patients with Chronic Kidney Disease and Type 2 DiabetesChronic Kidney Disease Stage 4MedDRA version: 14.1Level: SOCClassification code 10038359Term: Renal and urinary disordersSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2010-022297-14-ATReata Pharmaceuticals, Inc1,600
进行中（未招募）
1 期
The Evaluation of Bardoxolone Methyl in Patients with Chronic Kidney Disease and Type 2 DiabetesChronic Kidney Disease Stage 4MedDRA version: 14.1Level: SOCClassification code 10038359Term: Renal and urinary disordersSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2010-022297-14-BEReata Pharmaceuticals, Inc2,000
进行中（未招募）
不适用
The Evaluation of Bardoxolone Methyl in Patients with Chronic Kidney Disease and Type 2 DiabetesChronic Kidney Disease Stage 4MedDRA version: 14.1Level: SOCClassification code 10038359Term: Renal and urinary disordersSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2010-022297-14-CZReata Pharmaceuticals, Inc2,000